A Multicomponent Intervention to Improve Maternal Infection Outcomes.
Summary
In a cluster-randomized trial across 59 facilities (431,394 births) in Malawi and Uganda, the APT-Sepsis program reduced a composite of infection-related maternal death, near-miss, or severe infection from 1.9% to 1.4% (risk ratio 0.68, P<0.001). Effects were consistent across contexts and sustained, supporting implementation of WHO-aligned practices and the FAST-M bundle.
Key Findings
- Cluster-RCT across 59 facilities showed a reduction in composite infection-related outcomes from 1.9% to 1.4% (risk ratio 0.68; 95% CI 0.55–0.83; P<0.001).
- The intervention combined WHO hand hygiene, evidence-based practices, and the FAST-M (fluids, antibiotics, source control, transfer, monitoring) bundle.
- Effects were consistent across countries and facility sizes and were sustained over time.
Clinical Implications
Adoption of APT-Sepsis (WHO hand hygiene, evidence-based infection prevention/management, FAST-M) can reduce maternal infection-related morbidity/mortality. Health systems should implement and monitor bundle fidelity at scale.
Why It Matters
High-quality randomized evidence demonstrates that a scalable implementation program lowers maternal infection harm in LMICs, aligning with global priorities. The pragmatic design supports real-world adoption.
Limitations
- Potential contamination and varying fidelity across clusters; blinding not feasible.
- Generalizability beyond the two countries and to high-resource settings is uncertain.
Future Directions
Assess cost-effectiveness, implementation fidelity metrics, and adaptation/scale-up in diverse settings; evaluate patient-reported outcomes and neonatal impacts.
Study Information
- Study Type
- RCT
- Research Domain
- Prevention
- Evidence Level
- I - Cluster-randomized trial providing high-level causal evidence.
- Study Design
- OTHER